Showing results (1611-1620 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|September 29, 2009
Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodiesJoshua M Donaldson, Csaba Kari, Ruben C Fragoso, et al.Cancer Biology & Therapy|September 29, 2009
Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cellsWenjie Dong, Ruizhe Shen, Qi Wang, et al.Cancer Biology & Therapy|April 26, 2007
High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancersNaoshi Nishida, Takeshi Nagasaka, Kazuhiro Kashiwagi, et al.Cancer Biology & Therapy|April 12, 2007
LS14 cells: a model for chemoresistance in liposarcomaElizabeth W LaPensee, Shamantha P Reddy, Eric R Hugo, et al.Cancer Biology & Therapy|April 12, 2007
A new putative target for antisense gene therapy of glioma: glycogen synthaseMaryvonne Ardourel, Marion Blin, Jean-Luc Moret, et al.Cancer Biology & Therapy|April 12, 2007
Zebrafish tp53 knockdown extends the survival of irradiated zebrafish embryos more effectively than the p53 inhibitor pifithrin-alphaKevin T Duffy, Eric WickstromCancer Biology & Therapy|April 12, 2007
A novel polypeptide from shark cartilage with potent anti-angiogenic activityLanhong Zheng, Peixue Ling, Zheng Wang, et al.Cancer Biology & Therapy|July 10, 2007
Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cellsAngela Papageorgiou, Colin P N Dinney, David J McConkeyCancer Biology & Therapy|September 6, 2007
MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoingMatthias Christgen, Ulrich LehmannCancer Biology & Therapy|September 18, 2007
Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin alpha on tumor cells by suppressing NFkappaB signalingYijun Shen, Tong Yang, Jing Wang, et al.Pageof 388